Gelfoam is a medical device made of absorbable collagen that is used for several medical purposes and for controlling mucous or blood flow in a localized area. It is commonly used for treating nosebleeds, packing open wounds, stopping the bleeding of hemangiomas, and for controlling dental bleeding. Gelfoam is also frequently used in cardiovascular, gynecological, and neurosurgery procedures.
It is available in a variety of forms including sponges, sheets, and pellets and is available for purchase in medical supply stores and online retailers. It is absorbed into the body after about two to six weeks and is considered low risk if it enters the body unintentionally.
Gelfoam is produced and sold by several companies including Pfizer, Johnson & Johnson, and 3M. It is available in a variety of countries around the world, including the United States, Canada, Australia, and European countries.
The global Gelfoam market was valued at US$ 916.3 million in 2022 and is anticipated to reach US$ 1260 million by 2029, witnessing a CAGR of 4.6% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
A detailed market research report on Global Gelfoam Market available at: https://www.themarketreports.com/report/global-gelfoam-market-research-report
This report aims to provide a comprehensive presentation of the global market for Gelfoam, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gelfoam.
Market competition is not intense. Johnson & Johnson, Gelita, Pfizer, Baxter, Ferrosan Medical Devices, B Braun and Equimedical, etc. are the leaders of the industry, with about 92% market shares.
Ask for more details or sample of this report at: https://www.themarketreports.com/report/ask-your-query/1364544
The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479